Yahoo
NYSE American - Delayed Quote USD

Lineage Cell Therapeutics, Inc. (LCTX)

1.0000 -0.0300 (-2.91%)
At close: October 30 at 4:00:00 PM EDT
1.0169 +0.0169 (+1.69%)
After hours: October 30 at 5:02:01 PM EDT
Trade LCTX on Coinbase

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
252.91M 326.58M 393.56M 384.65M 385.92M 207.21M
Enterprise Value
203.26M 274.41M 338.99M 345.54M 344.52M 160.18M
Trailing P/E
-- -- -- -- -- --
Forward P/E
-- -- -- -- -- --
PEG Ratio (current)
-- -- -- -- -- --
Price/Sales
18.90 -- -- -- -- --
Price/Book
4.15 -- -- -- -- --
Enterprise Value/Revenue
15.54 18.57 23.29 31.95 31.57 16.76
Enterprise Value/EBITDA
-- -- -- -- -- --
6/30/2025 - 3/5/1992

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2025
Most Recent Quarter (mrq) 6/30/2026

Profitability

Profit Margin -246.58%
Operating Margin (ttm) -834.70%

Management Effectiveness

Return on Assets (ttm) -17.04%
Return on Equity (ttm) -60.06%

Income Statement

Revenue (ttm) 13.08M
Revenue Per Share (ttm) 0.05
Quarterly Revenue Growth (yoy) -61.30%
Gross Profit (ttm) -7.5M
EBITDA -26.11M
Net Income Avi to Common (ttm) -32.26M
Diluted EPS (ttm) -0.1900
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 50.83M
Total Cash Per Share (mrq) 0.2
Total Debt (mrq) 2.3M
Total Debt/Equity (mrq) 3.84%
Current Ratio (mrq) 6.61
Book Value Per Share (mrq) 0.24

Cash Flow Statement

Operating Cash Flow (ttm) -23.82M
Levered Free Cash Flow (ttm) -14.77M

Trading Information

Stock Price History

Beta (5Y Monthly) 1.60
52 Week Change 3 -48.98%
S&P 500 52-Week Change 3 10.63%
52 Week High 3 2.0900
52 Week Low 3 0.8800
50-Day Moving Average 3 1.0164
200-Day Moving Average 3 1.3263

Share Statistics

Avg Vol (3 month) 3 1.25M
Avg Vol (10 day) 3 1.26M
Shares Outstanding 5 252.91M
Implied Shares Outstanding 6 252.91M
Float 8 191.05M
% Held by Insiders 1 4.86%
% Held by Institutions 1 48.39%
Shares Short (10/15/2026) 4 25.93M
Short Ratio (10/15/2026) 4 15.4
Short % of Float (10/15/2026) 4 17.00%
Short % of Shares Outstanding (10/15/2026) 4 10.25%
Shares Short (prior month 9/15/2026) 4 29.47M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 0.00%
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 3:1
Last Split Date 3 10/31/1997

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: